| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1995;109:49-59
© 1995 Mosby, Inc.
CARDIAC AND PULMONARY REPLACEMENT |
Pittsburgh, Pa.
Address for reprints: Bartley P. Griffith, MD, Division of Cardiothoracic Surgery, University of Pittsburgh, C-700 Presbyterian University Hospital, Pittsburgh, PA 15213.
Abstract
Infection and rejection remain the greatest threats to the survival of pulmonary allograft recipients. Furthermore, a relationship may exist between these events, because the occurrence of one may predispose to the other. By using multivariate analysis for repeated events, we analyzed the risk factors for bacterial, fungal, and viral infection, grade II or greater acute rejection, and death among 239 lung transplant recipients who received 250 allografts between January 1988 and September 1993. A total of 90 deaths, 491 episodes of acute rejection, and 542 infectious episodes occurred during a follow-up of 6 to 71 months. The hazard or risk patterns of death, infection, and rejection each followed an extremely high risk during the first 100 days after transplantation, a second modest risk period at 800 to 1200 days, and a lower constant risk. Infection and graft failure manifested by diffuse alveolar damage were the major causes of early death (<100 days), whereas infection and chronic rejection were primary causes of later death after pulmonary transplantation. By multivariate analysis, cytomegalovirus mismatching risk for primary infection was the most significant risk factor for death, rejection, and infection. Absence of cytomegalovirus prophylaxis was also a risk factor for early and late death and late infection. Survival of recipients who received cytomegalovirus prophylaxis was significantly improved. Immunosuppression based on cyclosporine versus FK 506 was a risk factor for late death and late infection. Graft failure manifested by diffuse alveolar damage/adult respiratory distress syndrome was a significant risk for death late after transplantation. These data suggest the following: (1) The hazard for death, infection, and rejection after pulmonary transplantation appears biphasic; (2) lower survival is associated with ischemia-reperfusion lung injury represented by diffuse alveolar damage/adult respiratory distress syndrome; (3) cytomegalovirus mismatch, absence of cytomegalovirus prophylaxis, and development of cytomegalovirus disease are significant threats for death, rejection, and infection after pulmonary transplantation; (4) prevention of cytomegalovirus disease should improve survival by decreasing the prevalence of infection and rejection. (J THORAC CARDIOVASC SURG 1995;109:49-59)
This article has been cited by other articles:
|
|
 |
|
  B. P. Griffith, M. Haddad, and R. S. Poston Immunobiology of Heart and Heart-Lung Transplantation Card. Surg. Adult, January 1, 2008; 3(2008): 1513 - 1538. [Full Text]
|
|
|
|
 |
|
 M. J. Russo, D. I. Sternberg, K. N. Hong, R. A. Sorabella, A. J. Moskowitz, A. C. Gelijns, J. R. Wilt, F. D'Ovidio, S. M. Kawut, S. M. Arcasoy, et al. Postlung Transplant Survival is Equivalent Regardless of Cytomegalovirus Match Status Ann. Thorac. Surg., October 1, 2007; 84(4): 1129 - 1135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Taylor and S. M. Palmer Critical Care Perspective on Immunotherapy in Lung Transplantation J Intensive Care Med, December 1, 2006; 21(6): 327 - 344. [Abstract] [PDF]
|
|
|
|
 |
|
 T. D. Nielsen, T. Bahnson, R. D. Davis, and S. M. Palmer Atrial Fibrillation After Pulmonary Transplant Chest, August 1, 2004; 126(2): 496 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. DeVito Dabbs, L. A. Hoffman, A. T. Iacono, C. L. Wells, W. Grgurich, T. G. Zullo, K. R. McCurry, and J. H. Dauber Pattern and Predictors of Early Rejection After Lung Transplantation Am. J. Crit. Care., November 1, 2003; 12(6): 497 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Chalermskulrat, I. P. Neuringer, J. L. Schmitz, D. J. Catellier, M. J. Gurka, S. H. Randell, and R. M. Aris Human Leukocyte Antigen Mismatches Predispose to the Severity of Bronchiolitis Obliterans Syndrome After Lung Transplantation Chest, June 1, 2003; 123(6): 1825 - 1831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zuckermann, H. Reichenspurner, T. Birsan, H. Treede, E. Deviatko, B. Reichart, and W. Klepetko Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: One-year results of a 2-center prospective randomized trial J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 891 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Griffith and R. S. Poston Immunobiology of Heart and Heart-Lung Transplantation Card. Surg. Adult, January 1, 2003; 2(2003): 1403 - 1426. [Full Text]
|
|
|
|
|
|
S. M. Fiser, C. G. Tribble, A. K. Kaza, S. M. Long, J. A. Kern, D. C. Cassada, J. Linden, J. Rieger, V. E. Laubach, A. Matisoff, et al. Adenosine A2A receptor activation decreases reperfusion injury associated with high-flow reperfusion J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 973 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Pereszlenyi, G. Lang, H. Steltzer, H. Hetz, A. Kocher, P. Neuhauser, W. Wisser, and W. Klepetko Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 858 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Fiser, C. G. Tribble, S. M. Long, A. K. Kaza, J. T. Cope, V. E. Laubach, J. A. Kern, and I. L. Kron Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response J. Thorac. Cardiovasc. Surg., June 1, 2001; 121(6): 1069 - 1075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Fiser, C. G. Tribble, S. M. Long, A. K. Kaza, J. A. Kern, and I. L. Kron Pulmonary macrophages are involved in reperfusion injury after lung transplantation Ann. Thorac. Surg., April 1, 2001; 71(4): 1134 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. SCHULMAN, A. D. WEINBERG, C. C. McGREGOR, N. M. SUCIU-FOCA, and S. ITESCU Influence of Donor and Recipient HLA Locus Mismatching on Development of Obliterative Bronchiolitis after Lung Transplantation Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 437 - 442. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Schutte, M. Witzenrath, K. Mayer, N. Weissmann, A. Schell, S. Rosseau, W. Seeger, and F. Grimminger The PDE inhibitor zaprinast enhances NO-mediated protection against vascular leakage in reperfused lungs Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L496 - L502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Collins, N. L. Muller, E. A. Kazerooni, and G. Paciocco CT Findings of Pneumonia After Lung Transplantation Am. J. Roentgenol., September 1, 2000; 175(3): 811 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Levine, K. Parkes, S. Rooney, and R. S. Bonser Reduction of endothelial injury after hypothermic lung preservation by initial leukocyte-depleted reperfusion J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 47 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hasegawa, A. T. Iacono, P. D. Orons, and S. A. Yousem Segmental nonanastomotic bronchial stenosis after lung transplantation Ann. Thorac. Surg., April 1, 2000; 69(4): 1020 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. G. Blankenberg, R. C. Robbins, J. H. Stoot, P. W. Vriens, G. J. Berry, J. F. Tait, and H. W. Strauss Radionuclide Imaging of Acute Lung Transplant Rejection With Annexin V Chest, March 1, 2000; 117(3): 834 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Toda, K. Kayano, A. Karimova, Y. Naka, T. Fujita, K. Minamoto, C. Y. Wang, and D. J. Pinsky Antisense Intercellular Adhesion Molecule-1 (ICAM-1) Oligodeoxyribonucleotide Delivered During Organ Preservation Inhibits Posttransplant ICAM-1 Expression and Reduces Primary Lung Isograft Failure Circ. Res., February 4, 2000; 86(2): 166 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. G. Sia and R. Patel New Strategies for Prevention and Therapy of Cytomegalovirus Infection and Disease in Solid-Organ Transplant Recipients Clin. Microbiol. Rev., January 1, 2000; 13(1): 83 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. HIRSCH, A. ELSSNER, G. MAZUR, K. L. MAIER, I. BITTMANN, J. BEHR, M. SCHWAIBLMAIR, H. REICHENSPURNER, H. FÜRST, J. BRIEGEL, et al. Bronchiolitis Obliterans Syndrome after (Heart-)Lung Transplantation . Impaired Antiprotease Defense and Increased Oxidant Activity Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1640 - 1646. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. M. Arcasoy and R. M. Kotloff Lung Transplantation N. Engl. J. Med., April 8, 1999; 340(14): 1081 - 1091. [Full Text] [PDF]
|
|
|
|
|
|
A. N. HUSAIN, M. T. SIDDIQUI, E. W. HOLMES, A. J. CHANDRASEKHAR, M. MCCABE, R. RADVANY, and E. R. GARRITY Jr. Analysis of Risk Factors for the Development of Bronchiolitis Obliterans Syndrome Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 829 - 833. [Abstract] [Full Text]
|
|
|
|
|
|
J. C. Wain, C. D. Wright, D. P. Ryan, S. L. Zorb, D. J. Mathisen, and L. C. Ginns Induction immunosuppression for lung transplantation with OKT3 Ann. Thorac. Surg., January 1, 1999; 67(1): 187 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. SCHULMAN, A. D. WEINBERG, C. MCGREGOR, M. E. GALANTOWICZ, N. M. SUCIU-FOCA, and S. ITESCU Mismatches at the HLA-DR and HLA-B Loci Are Risk Factors for Acute Rejection after Lung Transplantation Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1833 - 1837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Keenan, H. Konishi, A. Kawai, I. L. Paradis, D. R. Nunley, A. T. Iacono, R. L. Hardesty, R. J. Weyant, and B. P. Griffith Clinical Trial of Tacrolimus Versus Cyclosporine in Lung Transplantation Ann. Thorac. Surg., September 1, 1995; 60(3): 580 - 584. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
